Clinical Trial Update: Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fostamatinib 200 mg for diffuse large B-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-22